when you peel the veneer away, they are enablers, persons of interest, co-conspirators..
biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
comments.
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..
0 comments
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..
.